1. Home
  2. FLUX vs TCRT Comparison

FLUX vs TCRT Comparison

Compare FLUX & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flux Power Holdings Inc.

FLUX

Flux Power Holdings Inc.

SELL

Current Price

$0.25

Market Cap

7.1M

Sector

Miscellaneous

ML Signal

SELL

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

SELL

Current Price

$1.61

Market Cap

7.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FLUX
TCRT
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
7.8M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
FLUX
TCRT
Price
$0.25
$1.61
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $1.87
N/A
AVG Volume (30 Days)
135.5K
★ 1.5M
Earning Date
11-03-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
★ 24.66
EPS
★ N/A
N/A
Revenue
$9,317,000.00
★ $15,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$85.96
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 126.25
N/A
52 Week Low
$0.28
$0.72
52 Week High
$1.83
$4.50

Technical Indicators

Market Signals
Indicator
FLUX
TCRT
Relative Strength Index (RSI) 28.05 45.08
Support Level N/A $1.61
Resistance Level $0.48 $2.09
Average True Range (ATR) 0.05 0.17
MACD -0.01 -0.06
Stochastic Oscillator 0.43 20.34

Price Performance

Historical Comparison
FLUX
TCRT

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc. designs, develops, manufactures, and sells a portfolio of lithium-ion energy storage solutions for the electrification of a range of industrial and commercial sectors, which include material handling, airport ground support equipment (GSE), and stationary energy storage. It offers a high-power battery cell management system(BMS). The BMS serves as the brain of the energy storage solution, managing cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company's product portfolio includes Battery Technology and Energy Management solutions.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Share on Social Networks: